Antipsychotic Risk Examined In NEJM; Did FDA Judge Atypicals Unfairly?

Conventional antipsychotic medications should not be prescribed as replacements for atypical products despite an FDA public health advisory about the newer agents because conventional medications appear to have higher mortality in elderly patients, an article in the Dec. 1 New England Journal of Medicine concludes